Literature DB >> 25277334

Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial).

Nirat Beohar1, Alan Zajarias2, Vinod H Thourani3, Howard C Herrmann4, Michael Mack5, Samir Kapadia6, Philip Green7, Suzanne V Arnold8, David J Cohen8, Philippe Généreux9, Ke Xu10, Martin B Leon9, Ajay J Kirtane9.   

Abstract

In high-risk or inoperable patients with severe symptomatic aortic stenosis, transcatheter aortic valve implantation (TAVI) is a proven alternative to standard (i.e., medical) therapy or surgical aortic valve replacement. Concerns have been raised, however, about patients who survive the procedure but have short subsequent survival. The aim of this study was therefore to identify correlates of early out-of-hospital mortality (EOHM) in patients who underwent successful TAVI, rendering TAVI potentially "futile." Patients who were discharged from the hospital and survived >30 days but <12 months after TAVI were identified (the EOHM group). Independent predictors of EOHM were explored, including patient-level factors and procedural nonfatal major complications (NFMCs). A sensitivity analysis was also performed, excluding patients with NFMCs. Among 485 patients who were discharged from the hospital and survived 30 days after TAVI, 101 (21%) were dead within 1 year. Independent predictors of EOHM included serum creatinine, liver disease, coagulopathy, mental status, body mass index, male gender, and Society of Thoracic Surgeons score. Although NFMCs were strongly associated with EOHM, patient-level risk factors for EOHM were similar between patients who did and those who did not experience NFMCs. Compared with standard therapy, TAVI patients with EOHM had similar 6-month 6-minute walk distances and functional classes, with higher rates of repeat hospitalization. In conclusion, in high-risk or inoperable patients who underwent TAVI and were discharged and alive at 30 days, EOHM was not infrequent and was determined largely by presenting characteristics and the occurrence of periprocedural NFMCs. Careful screening and minimization of NFMCs may maximize the benefit of TAVI.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25277334      PMCID: PMC4482466          DOI: 10.1016/j.amjcard.2014.08.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  The risk of surgery in patients with liver disease.

Authors:  L S Friedman
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

3.  Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes.

Authors:  John G Webb; Lukas Altwegg; Robert H Boone; Anson Cheung; Jian Ye; Samuel Lichtenstein; May Lee; Jean Bernard Masson; Christopher Thompson; Robert Moss; Ron Carere; Brad Munt; Fabian Nietlispach; Karin Humphries
Journal:  Circulation       Date:  2009-06-01       Impact factor: 29.690

4.  The EuroSCORE - still helpful in patients undergoing isolated aortic valve replacement?

Authors:  Daniel Wendt; Brigitte Osswald; Matthias Thielmann; Katrin Kayser; Paschalis Tossios; Parwis Massoudy; Markus Kamler; Heinz Jakob
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-11-19

5.  EuroSCORE performance in valve surgery: a meta-analysis.

Authors:  Alessandro Parolari; Lorenzo L Pesce; Matteo Trezzi; Laura Cavallotti; Samer Kassem; Claudia Loardi; Davide Pacini; Elena Tremoli; Francesco Alamanni
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

6.  Two-year outcomes after transcatheter or surgical aortic-valve replacement.

Authors:  Susheel K Kodali; Mathew R Williams; Craig R Smith; Lars G Svensson; John G Webb; Raj R Makkar; Gregory P Fontana; Todd M Dewey; Vinod H Thourani; Augusto D Pichard; Michael Fischbein; Wilson Y Szeto; Scott Lim; Kevin L Greason; Paul S Teirstein; S Chris Malaisrie; Pamela S Douglas; Rebecca T Hahn; Brian Whisenant; Alan Zajarias; Duolao Wang; Jodi J Akin; William N Anderson; Martin B Leon
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

7.  Cognitive impairment and risk of cardiovascular events and mortality.

Authors:  Martin O'Donnell; Koon Teo; Peggy Gao; Craig Anderson; Peter Sleight; Antonio Dans; Irene Marzona; Jackie Bosch; Jeff Probstfield; Salim Yusuf
Journal:  Eur Heart J       Date:  2012-05-02       Impact factor: 29.983

8.  Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis.

Authors:  Marco Ranucci; Umberto Di Dedda; Serenella Castelvecchio; Lorenzo Menicanti; Alessandro Frigiola; Gabriele Pelissero
Journal:  Ann Thorac Surg       Date:  2012-06-13       Impact factor: 4.330

9.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

10.  Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement.

Authors:  Todd M Dewey; David Brown; William H Ryan; Morley A Herbert; Syma L Prince; Michael J Mack
Journal:  J Thorac Cardiovasc Surg       Date:  2007-11-26       Impact factor: 5.209

View more
  4 in total

1.  Resistin-induced cardiomyocyte hypertrophy is inhibited by apelin through the inactivation of extracellular signal-regulated kinase signaling pathway in H9c2 embryonic rat cardiomyocytes.

Authors:  Jian-Wei Luo; Xian Zheng; Guan-Chang Cheng; Qun-Hui Ye; Yong-Zhi Deng; Lin Wu
Journal:  Biomed Rep       Date:  2016-09-02

Review 2.  Multimorbidity in Older Adults with Aortic Stenosis.

Authors:  Brian R Lindman; Jay N Patel
Journal:  Clin Geriatr Med       Date:  2016-02-12       Impact factor: 3.076

3.  Clinical outcomes of patients with hepatic insufficiency undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis.

Authors:  Wenkai Jiang; Zeyi Cheng; Shiyan Tu; Xing Wang; Caifei Xiang; Wence Zhou; Lin Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-02-23       Impact factor: 2.298

4.  Rise and fall of NT-proBNP in aortic valve intervention.

Authors:  Henrik Hultkvist; Jonas Holm; Rolf Svedjeholm; Farkas Vánky
Journal:  Open Heart       Date:  2018-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.